Clik here to view.
CDISC and Cohen Veterans Bioscience Announce Release of First Data Standard...
AUSTIN, Texas CDISC and Cohen Veterans Bioscience are pleased to announce the publication of a new Therapeutic Area (TA) Standard for Post Traumatic Stress Disorder released in the form of a User...
View ArticleClik here to view.
Haidian District People’s Court in Beijing Issues Injunction Order...
BEIJING Sinovac Biotech Ltd. (“Sinovac” or the “Company”) announced that the People’s Court in Haidian District, Beijing (the “Court”), has issued an interim injunction order restraining Mr. Aihua...
View ArticleClik here to view.
武田和纽约科学院宣布2019年度科学创新者奖获奖人
纽约市和日本大阪 (美国商业资讯) — 武田药品工业株式会社（Takeda Pharmaceutical Company Limited，简称“武田”）(TSE:4502)和纽约科学院今天宣布了每年一次的科学创新者奖第二年的获奖人，以表彰他们在再生医学领域的承诺和卓越贡献。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Tilray®宣布成立国际顾问委员会
不列颠哥伦比亚省纳奈莫 (美国商业资讯)–大麻生产和分销的全球先锋企业Tilray, Inc. (NASDAQ:TLRY)今天宣布成立国际顾问委员会。委员会由多位备受尊敬的企业和政府领袖组成，将在Tilray执行积极的全球增长战略过程中为公司高管团队和董事会提供指引。 Tilray首席执行官Brendan...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
Celltrion and Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a...
INCHEON, South Korea & JERUSALEM Celltrion, Inc. (KRX:068270) and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has...
View ArticleClik here to view.
ティルレイが国際諮問委員会の設立を発表
加ブリティッシュコロンビア州ナナイモ （ビジネスワイヤ） — カンナビス生産販売の世界的パイオニア企業ティルレイ（NASDAQ:TLRY）は本日、国際諮問委員会の設立を発表しました。本委員会は、実業界と政界のリーダーらで構成される尊敬すべきグループで、ティルレイが積極的な世界的成長戦略を追求する際に、当社経営陣と取締役会に指針を与えていきます。...
View ArticleClik here to view.
Fuji Pharma Invests in Alvotech for US$50 Million
TOKYO & REYKJAVIK, Iceland Biopharmaceutical company Alvotech announced today that Japan-based Fuji Pharma has acquired a 4.2% stake in the business for approximately US$50 million. This press...
View ArticleClik here to view.
Vernalis Research, a Ligand Company, Achieves Success Milestone in...
CAMBRIDGE, England Vernalis Research, a Ligand Company, announced the achievement of a £1 million success milestone in its drug discovery collaboration with Asahi Kasei Pharma (AKP). This...
View ArticleClik here to view.
Aptorum Group Limited Announces Closing of Initial Public Offering
HONG KONG Aptorum Group Limited (“Aptorum”, or the “Company”), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic...
View ArticleClik here to view.
AVITA Medical Announces Receipt of A$1.4 Million Research and Development Tax...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that it has received a Research and Development Tax...
View ArticleClik here to view.
武田薬品、未治療のCD30陽性ステージ4ホジキンリンパ腫成人患者を治療するためのアドセトリス（ブレンツキシマブ・ベドチン）とAVDの併用に関するCHMPの...
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社(TSE:...
View ArticleClik here to view.
富士制药向Alvotech投资5000万美元
东京和冰岛雷克雅未克 — (美国商业资讯) — 生物制药公司Alvotech今天宣布，总部位于日本的富士制药出资约5000万美元收购其4.2%的股权。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20181218005337/zh-CN/ Biopharmaceutical company Alvotech...
View ArticleClik here to view.
武田获得CHMP肯定意见，接纳ADCETRIS® (brentuximab vedotin)联合AVD用于治疗既往未曾治疗的CD30+...
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，欧洲药品管理局(EMA)人用药品委员会(CHMP)采纳了一项肯定意见，延长ADCETRIS (brentuximab vedotin)的上市许可，并推荐核准该药联合AVD用于既往未曾治疗的CD30+...
View ArticleClik here to view.
Takeda Announces Listing of American Depositary Shares on the New York Stock...
OSAKA, Japan NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH...
View ArticleClik here to view.
富士製薬がアルヴォテックに5000万米ドルを出資
東京 & アイスランド・レイキャビク — （ビジネスワイヤ） — バイオ製薬企業アルヴォテックは本日、日本に拠点を置く富士製薬が当社株式の4.2%を約5000万米ドルで取得したと発表しました。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：...
View ArticleClik here to view.
Akaal Pharmaがアトピー性皮膚炎と乾癬に対する画期的新薬の局所スフィンゴシン-1-リン酸受容体1型（S1P1）調節薬のライセンス契約を発表
豪メルボルン （ビジネスワイヤ） — Akaal Pharma Pty Limited（以下、Akaal...
View ArticleClik here to view.
Spirita Oncology Initiated Global Clinical Development of E6201 in...
BOSTON Spirita Oncology, LLC, announced that it has entered into a sublicense agreement with JS Innopharm (Shanghai) Ltd. to initiate global clinical development of E6201, a potent MEK1 inhibitor...
View ArticleClik here to view.
Sinovac Comments on Antigua and Barbuda Court Decision Denying 1Globe...
BEIJING Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the High Court of Justice of Antigua and...
View ArticleClik here to view.
クック ジャパン 新代表取締役就任のお知らせ
東京都中野区 （ビジネスワイヤ） — Cook Japan株式会社（本社：東京都中野区、以下「クック ジャパン」）は、このほどバリー・トーマス（Barry Thomas）が新たに代表取締役に就任したことを発表いたします。トーマスは、2001年にクック...
View Article